Latest Behring Stories
CSL Behring Recognized for its Longstanding Commitment to Delivering Innovative Products and Programs that Advance the Care of the Bleeding Disorders Community NEW YORK and KING OF PRUSSIA,
Industry serves critical role in advancing healthcare and improving the well-being of patients, says CSL CEO Paul Perreault SARDINIA, Italy, May 14, 2015 /PRNewswire/ -- Scientific advancements,
Company and Employees Cultivate a Culture of Giving, Including Partnering with Children's Scholarship Fund Philadelphia KING OF PRUSSIA, Pa., March 9, 2015 /PRNewswire/ -- CSL Behring announced
CSL Behring Pioneered Donations to WFH Program; Further Underscores Commitment to Providing Global Bleeding Disorders Community with Access to Treatment KING OF PRUSSIA, Pa., Feb.
New Label Supports Individualized Therapy Through Greater Dosing Flexibility From Daily to Once Every Two Weeks (Biweekly); Underscores CSL Behring's Commitment to Improving Patients' Lives
Led by CSL Behring performance, the company focuses on sustainable business practices, strong results to provide patients with lifesaving, life-enhancing therapies around the world. KING OF
Presentations focus on Hizentra flexible dosing regimens and push administration PRAGUE, Oct.
JNC is the Bleeding Disorders Community's Original Golf and Baseball Competition for Kids with Hemophilia and/or von Willebrand disease (VWD) and Their Families PHOENIX, Oct.
KING OF PRUSSIA, Pa., Oct.
CSL Plasma center openings are on the rise, as is the demand for plasma protein therapies for the treatment of rare and serious diseases. KING OF PRUSSIA, Pa., Oct.
- A hairdresser.